HDAC2 and neurodegenerative disease: In models of neurodegenerative diseases, it has been found that pharmacological inhibition of HDACs or HDAC2 silencing prevent histones hypoacetylation and increase gene expression [25, 28, 64], in addition to rescuing or reducing cognitive deficit.